Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction: A Multicenter Randomized Noninferiority Trial

NCT04769362 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04769362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04769362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction: A Multicenter Randomized Noninferiority Trial
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
May 4, 2021
Completion date
March 31, 2026
Enrollment
2,540 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction